Why Should You Put Teradyne, Inc (NASDAQ: TER) On Your Portfolio?

Currently, there are 161.72M common shares owned by the public and among those 157.47M shares have been available to trade.

The company’s stock has a 5-day price change of -18.80% and -23.43% over the past three months. TER shares are trading -30.85% year to date (YTD), with the 12-month market performance down to -20.84% lower. It has a 12-month low price of $95.80 and touched a high of $163.21 over the same period. TER has an average intraday trading volume of 2.69 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -20.97%, -27.46%, and -31.59% respectively.

Institutional ownership of Teradyne, Inc (NASDAQ: TER) shares accounts for 98.40% of the company’s 161.72M shares outstanding.

It has a market capitalization of $14.08B and a beta (3y monthly) value of 1.54. The stock’s trailing 12-month PE ratio is 26.24, while the earnings-per-share (ttm) stands at $3.32. The company has a PEG of 1.09 and a Quick Ratio of 1.84 with the debt-to-equity ratio at 0.03. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.93% over the week and 4.04% over the month.

Earnings per share for the fiscal year are expected to increase by 17.02%, and 42.34% over the next financial year. EPS should grow at an annualized rate of 24.16% over the next five years, compared to 4.98% over the past 5-year period.

Looking at the support for the TER, a number of firms have released research notes about the stock. Vertical Research stated their Buy rating for the stock in a research note on March 07, 2025, with the firm’s price target at $135. Morgan Stanley coverage for the Teradyne, Inc (TER) stock in a research note released on January 21, 2025 offered a Underweight rating with a price target of $117. Northland Capital was of a view on January 06, 2025 that the stock is Outperform, while JP Morgan gave the stock Overweight rating on December 16, 2024, issuing a price target of $145- $158. Cantor Fitzgerald on their part issued Overweight rating on August 16, 2024.

Most Popular

Related Posts